|
End-of-day quote
Shenzhen S.E.
09/09/2026
|
5-day change | 1st Jan Change | ||
| 173.05 CNY | -0.72% |
|
+5.13% | +86.22% |
Company Valuation: Asymchem Laboratories (Tianjin) Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 111,228 | 52,704 | 41,387 | 26,238 | 32,605 | 60,761 | - | - |
| Change | - | -52.62% | -21.47% | -36.6% | 24.27% | 86.35% | - | - |
| Enterprise Value (EV) 1 | 105,383 | 47,524 | 34,318 | 20,491 | 26,337 | 56,088 | 57,105 | 57,904 |
| Change | - | -54.9% | -27.79% | -40.29% | 28.53% | 112.96% | 1.81% | 1.4% |
| P/E | 99.1x | 16.4x | 18.5x | 28.3x | 29.4x | 46.1x | 34.8x | 28.6x |
| PBR | 9.07x | 3.5x | 2.46x | 1.66x | 1.9x | 3.33x | 3.11x | 2.87x |
| PEG | - | 0x | -0.6x | -0.5x | 1.7x | 2.5x | 1.1x | 1.3x |
| Capitalization / Revenue | 24x | 5.15x | 5.29x | 4.52x | 4.89x | 7.51x | 6.2x | 5.12x |
| EV / Revenue | 22.7x | 4.65x | 4.39x | 3.53x | 3.95x | 6.93x | 5.83x | 4.88x |
| EV / EBITDA | 75.3x | 13.6x | 11.2x | 16.1x | 15.1x | 25.5x | 20.8x | 17.6x |
| EV / EBIT | 88.4x | 15.2x | 13.3x | 19x | 22.5x | 34.7x | 28.3x | 24x |
| EV / FCF | -68.1x | 41.8x | 14.6x | 164x | 192x | -113x | 68.7x | 43.6x |
| FCF Yield | -1.47% | 2.39% | 6.84% | 0.61% | 0.52% | -0.88% | 1.46% | 2.29% |
| Dividend per Share 2 | 0.5714 | 1.8 | 1.8 | 1.1 | 1.3 | 1.353 | 1.808 | 2.133 |
| Rate of return | 0.18% | 1.22% | 1.55% | 1.45% | 1.4% | 0.78% | 1.04% | 1.23% |
| EPS 2 | 3.136 | 9 | 6.26 | 2.69 | 3.16 | 3.754 | 4.979 | 6.042 |
| Distribution rate | 18.2% | 20% | 28.8% | 40.9% | 41.1% | 36% | 36.3% | 35.3% |
| Net sales 1 | 4,639 | 10,230 | 7,825 | 5,805 | 6,670 | 8,089 | 9,803 | 11,873 |
| EBITDA 1 | 1,399 | 3,498 | 3,058 | 1,274 | 1,744 | 2,199 | 2,750 | 3,284 |
| EBIT 1 | 1,192 | 3,136 | 2,571 | 1,079 | 1,169 | 1,615 | 2,018 | 2,413 |
| Net income 1 | 1,069 | 3,302 | 2,269 | 949 | 1,133 | 1,352 | 1,795 | 2,317 |
| Net Debt 1 | -5,846 | -5,180 | -7,069 | -5,747 | -6,268 | -4,673 | -3,656 | -2,857 |
| Reference price 2 | 310.71 | 148.00 | 116.10 | 76.09 | 92.93 | 173.05 | 173.05 | 173.05 |
| Nbr of stocks (in thousands) | 368,307 | 364,755 | 364,426 | 354,879 | 359,442 | 359,630 | - | - |
| Announcement Date | 3/30/22 A | 3/30/23 A | 3/28/24 A | 3/28/25 A | 3/30/26 A | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 46.1x | 6.93x | 27.27x | 0.78% | 9.05B | |
| 32x | 11.63x | 23.59x | 0.62% | 1,002B | |
| 28.37x | 6.53x | 17.91x | 2.01% | 644B | |
| 32.13x | 7.46x | 15.49x | 2.73% | 443B | |
| 18.9x | 4.61x | 11.42x | 2.88% | 343B | |
| 19.46x | 5.11x | 12.69x | 3.2% | 262B | |
| 20.29x | 4.17x | 11.93x | 2.12% | 245B | |
| 24.75x | 6.5x | 11.57x | 2.58% | 212B | |
| 12.86x | 4.67x | 9.75x | 3.91% | 199B | |
| -44.5x | 6.43x | 25.11x | 2.26% | 181B | |
| Average | 19.04x | 6.40x | 16.67x | 2.31% | 353.87B | |
| Weighted average by Cap. | 22.97x | 7.53x | 17.34x | 2.04% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 002821 Stock
- Valuation Asymchem Laboratories (Tianjin) Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
